Table 1.
Clinicopathologic characteristics of the breast carcinoma patients.
| Characteristics | Cases |
|---|---|
| Age range | 23–91 |
| Age at diagnosis (mean ± SD) | 48.8 ± 10.9 |
| Menopausal status* | |
| Pre-menopausal | 235 |
| Post-menopausal | 263 |
| Tumor size* | |
| T0−2 | 254 |
| T3−4 | 157 |
| Regional lymph node involvement | |
| Positive (N1−3) | 208 |
| Negative (N0) | 306 |
| Histological grade* | |
| SBR1−2 | 322 |
| SBR3 | 172 |
| Pathological lymph node involvement | |
| Positive (pN1−3) | 323 |
| Negative (pN0) | 190 |
| Distant metastasis | |
| Positive (M1) | 79 |
| Negative (M0) | 465 |
| Relapse* | |
| Positive | 88 |
| Negative | 455 |
| Death record | |
| Positive | 11 |
| Negative | 533 |
| Estrogen receptor (ER) status* | |
| Positive | 277 |
| Negative | 222 |
| Progesterone receptor (PR) status* | |
| Positive | 233 |
| Negative | 268 |
| ER/PR status* | |
| ER+/PR+ | 206 |
| ER+/PR− | 70 |
| ER−/PR+ | 24 |
| ER−/PR− | 198 |
| Triple negative | |
| Yes | 196 |
| No | 348 |
*
Some data are missing.